Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy von Hathout, Yetrib, Brody, Edward, Clemens, Paula R., Cripe, Linda, DeLisle, Robert Kirk, Furlong, Pat, Gordish-Dressman, Heather, Hache, Lauren, Henricson, Erik, Hoffman, Eric P., Kobayashi, Yvonne Monique, Lorts, Angela, Mah, Jean K., McDonald, Craig, Mehler, Bob, Nelson, Sally, Nikrad, Malti, Singer, Britta, Steele, Fintan, Sterling, David, Sweeney, H. Lee, Williams, Steve, Gold, Larry

Volltext

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells von Johnson, Thomas R, Stone, Kimberley, Nikrad, Malti, Yeh, Tammie, Zong, Wei-Xing, Thompson, Craig B, Nesterov, Alexandre, Kraft, Andrew S

Volltext

The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim von Nikrad, Malti, Johnson, Thomas, Puthalalath, Hamsa, Coultas, Leigh, Adams, Jerry, Kraft, Andrew S

Volltext

Mo1003 Novel Serum Protein Signature Associated With Non-Alcoholic Fatty Liver Disease von Nikrad, Malti P, Field, Stuart G, Mehler, Robert, Williams, Stephen, Still, Christopher D, Argyropoulos, George, Chu, Xin, Gerhard, Glenn

Volltext

307 Discovery and Validation of a Novel Serum Protein Signature Associated With Non-Alcoholic Fatty Liver Disease in Adult and Pediatric Populations von Nikrad, Malti P, Field, Stuart G, Williams, Stephen, Argyropoulos, George, Chu, Xin, Still, Christopher D, Wood, G. Craig, Biank, Vincent, Gerhard, Glenn S

Volltext

Aptamer-based multiplexed proteomic technology for biomarker discovery von Gold, Larry, Ayers, Deborah, Bertino, Jennifer, Bock, Christopher, Bock, Ashley, Brody, Edward N, Carter, Jeff, Dalby, Andrew B, Eaton, Bruce E, Fitzwater, Tim, Flather, Dylan, Forbes, Ashley, Foreman, Trudi, Fowler, Cate, Gawande, Bharat, Goss, Meredith, Gunn, Magda, Gupta, Shashi, Halladay, Dennis, Heil, Jim, Heilig, Joe, Hicke, Brian, Husar, Gregory, Janjic, Nebojsa, Jarvis, Thale, Jennings, Susan, Katilius, Evaldas, Keeney, Tracy R, Kim, Nancy, Koch, Tad H, Kraemer, Stephan, Kroiss, Luke, Le, Ngan, Levine, Daniel, Lindsey, Wes, Lollo, Bridget, Mayfield, Wes, Mehan, Mike, Mehler, Robert, Nelson, Sally K, Nelson, Michele, Nieuwlandt, Dan, Nikrad, Malti, Ochsner, Urs, Ostroff, Rachel M, Otis, Matt, Parker, Thomas, Pietrasiewicz, Steve, Resnicow, Daniel I, Rohloff, John, Sanders, Glenn, Sattin, Sarah, Schneider, Daniel, Singer, Britta, Stanton, Martin, Sterkel, Alana, Stewart, Alex, Stratford, Suzanne, Vaught, Jonathan D, Vrkljan, Mike, Walker, Jeffrey J, Watrobka, Mike, Waugh, Sheela, Weiss, Allison, Wilcox, Sheri K, Wolfson, Alexey, Wolk, Steven K, Zhang, Chi, Zichi, Dom

Volltext

Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-α-related apoptosis-inducing ligand-induced apoptosis von NESTEROV, Alexandre, NIKRAD, Malti, JOHNSON, Thomas, KRAFT, Andrew S

Volltext

Preoteomic insights in oncology: What have we learned from measuring millions of proteins? von Brody, Ed, Foreman, Trudi, Gill, Rosalynn D, Mehan, Mike, Nikrad, Malti, Ostroff, Rachel, Stewart, Alex, Williams, Steve, Zichi, Dom

Volltext

New SOMAmer-based assay to discover biomarkers relevant to malignant melanoma von Robinson, William, Nikrad, Malti P., Robinson, Steven, Williams, Stephen, Ostroff, Rachel

Volltext

Detection of rare cancers with aptamer proteomic technology von Ostroff, Rachel, Nikrad, Malti, Williams, Steven, Stewart, Alex, Mehan, Mike, Brand, Randall, Moser, James, Zeh, Herbert, Pass, Harvey, Levin, Stephen, Black, Brad, Harbut, Michael

Volltext

NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF von NIKRAD, Malti, FIELD, Stuart G, WILLIAMS, Stephen Alaric

Volltext bestellen

NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF von NIKRAD, Malti, FIELD, Stuart G, WILLIAMS, Stephen Alaric

Volltext bestellen

APTAMERS AND DIAGNOSTIC METHODS FOR DETECTING THE EGF RECEPTOR von GAWANDE, Bharat Nathu, NIKRAD, Malti P

Volltext bestellen

NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF von NIKRAD, Malti, FIELD, Stuart G, WILLIAMS, Stephen Alaric

Volltext bestellen

Biomarkører for non-alkoholisk fedtleversygdom (NAFLD) og non-alkoholisk steatohepatitis (NASH) og anvendelser deraf von NIKRAD, Malti, FIELD, Stuart G, WILLIAMS, Stephen Alaric

Volltext bestellen

Biomarcadores de la enfermedad de hígado graso no alcohólico (EHGNA) y de la esteatohepatitis no alcohólica (EHNA) y usos de los mismos von NIKRAD, Malti, FIELD, Stuart G, WILLIAMS, Stephen Alaric

Volltext bestellen

NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF von NIKRAD, Malti, FIELD, Stuart G, WILLIAMS, Stephen Alaric

Volltext bestellen

NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF von STUART G FIELD, STEPHEN ALARIC WILLIAMS, MALTI NIKRAD

Volltext bestellen

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof von Nikrad, Malti, Williams, Stephen Alaric, Field, Stuart G

Volltext bestellen

Métodos para determinar se um indivíduo com esteatose não alcoólica tem esteato-hepatite não alcoólica e para monitorar um indivíduo com esteatose não alcoólica para o desenvolvime... von STUART G. FIELD, STEPHEN ALARIC WILLIAMS, NIKRAD MALTI

Volltext bestellen